Contact
Please use this form to send email to PR contact of this press release:
Zogenix Receives Fast Track Designation From FDA for Development of ZX008 in Dravet Syndrome
TO:
Please use this form to send email to PR contact of this press release:
Zogenix Receives Fast Track Designation From FDA for Development of ZX008 in Dravet Syndrome
TO: